{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T02:47:11Z","timestamp":1767408431122},"reference-count":36,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.08.008","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:38:18Z","timestamp":1282466298000},"page":"7081-7091","source":"Crossref","is-referenced-by-count":23,"title":["Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys"],"prefix":"10.1016","volume":"28","author":[{"given":"Rafal J.","family":"Zielinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy V.","family":"Smedley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin-Yu","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Silvera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Capala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyanage P.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.008_bib0005","series-title":"Smallpox and its eradication. History of International Public Health","author":"Fenner","year":"1988"},{"key":"10.1016\/j.vaccine.2010.08.008_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0923-2516(89)80126-8","article-title":"Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign","volume":"140","author":"Fenner","year":"1989","journal-title":"Res Virol"},{"key":"10.1016\/j.vaccine.2010.08.008_bib0015","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2010.08.008_bib0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.008_bib0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"16","key":"10.1016\/j.vaccine.2010.08.008_bib0030","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1128\/JVI.00538-07","article-title":"Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice","volume":"81","author":"Perera","year":"2007","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.008_bib0035","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/JVI.66.5.2934-2942.1992","article-title":"Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor","volume":"66","author":"Alexander","year":"1992","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.008_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2010.08.008_bib0045","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1099\/vir.0.2008\/004440-0","article-title":"Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax","volume":"89","author":"Midgley","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.08.008_bib0050","series-title":"Recombinant poxviruses","first-page":"235","article-title":"Safety and attenuation of vaccinia viruses","author":"Buller","year":"1992"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.008_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.gt.3302840","article-title":"Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice","volume":"14","author":"Hung","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.008_bib0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.008_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.008_bib0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/cimm.1993.1307","article-title":"Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responses","volume":"152","author":"H\u00fcgin","year":"1993","journal-title":"Cell Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.008_bib0075","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1073\/pnas.081080298","article-title":"Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice","volume":"98","author":"Perera","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2010.08.008_bib0080","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nbt1007-1084","article-title":"Alliance for biosecurity. The FDA animal efficacy rule and biodefense","volume":"25","author":"Gronvall","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"105","key":"10.1016\/j.vaccine.2010.08.008_bib0085","first-page":"37988","article-title":"HHS New drug and biological drug products; evidence needed demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule","volume":"67","year":"2002","journal-title":"Fed Regist"},{"issue":"6145","key":"10.1016\/j.vaccine.2010.08.008_bib0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/330259a0","article-title":"Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression","volume":"330","author":"Flexner","year":"1987","journal-title":"Nature"},{"issue":"6139","key":"10.1016\/j.vaccine.2010.08.008_bib0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/329545a0","article-title":"Recovery of immunodeficient mice from a vaccinia virus\/IL-2 recombinant infection","volume":"329","author":"Ramshaw","year":"1987","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.008_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0264-410X(90)90171-H","article-title":"Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2","volume":"8","author":"Flexner","year":"1990","journal-title":"Vaccine"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2010.08.008_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/icb.1990.16","article-title":"Response of monkeys to vaccination with recombinant vaccinia virus which coexpress HIV gp160 and human interleukin-2","volume":"68","author":"Ruby","year":"1990","journal-title":"Immunol Cell Biol"},{"issue":"6979","key":"10.1016\/j.vaccine.2010.08.008_bib0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vaccine.2010.08.008_bib0115","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.008_bib0120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.008_bib0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2007.10.063","article-title":"Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge","volume":"26","author":"Marriott","year":"2008","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2010.08.008_bib0130","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.vaccine.2010.08.008_bib0135","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.1128\/JVI.00689-09","article-title":"Expansion, reexpansion, and recall-like expansion of Vgamma2Vdelta2 T cells in smallpox vaccination and monkeypox virus infection","volume":"83","author":"Shao","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.008_bib0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.08.008_bib0145","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.0630592100","article-title":"Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity","volume":"100","author":"Oh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2010.08.008_bib0150","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.08.008_bib0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2010.08.008_bib0160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2010.08.008_bib0165","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.08.008_bib0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-540-92165-3_18","article-title":"Microneedle-based vaccines","volume":"333","author":"Prausnitz","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"27","key":"10.1016\/j.vaccine.2010.08.008_bib0175","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1016\/j.vaccine.2009.03.062","article-title":"Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration","volume":"27","author":"K\u00fcnzi","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.008_bib0180","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nm.2078","article-title":"Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity","volume":"16","author":"Liu","year":"2010","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T20:34:16Z","timestamp":1591821256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":36,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10011175"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}